Terry Opgenorth - C2D2 (Colorado Center For Drug Discovery)

Recorded on April 20, 2010, at the Colorado BioScience Association (CBSA) Annual All-Member Meeting. The Colorado Center for Drug Discovery (C2D2) fills a gap in drug-discovery at CO research universities. The C2D2 provides medicinal chemistry, pharmacokinetics, and consulting resources to create new patent-protected compounds useful for validation of novel drug discovery targets and drug candidates for clinical development by Colorado biopharma companies and others. This grant supports the C2D2 as a resource to faculty at Colorado research universities, bringing biology and chemistry faculty together to use chemical libraries, computational resources, bioinformatics, cheminformatics, database support, virtual high throughput screening, and Computer Aided Drug Design to pharmacologically validate drug candidates with patent-protected chemical matter and innovative therapeutics for unmet medical needs. Furthermore, the infrastructure and framework of expertise created by C2D2 across Colorado research universities will expand opportunities for emerging Colorado bioscience companies to access critical expertise and resources that would be difficult to establish within these companies.

Category:

Science & Technology

Tags:

• Colorado
• science
• bioscience
• biotechnology
• drug discovery